Summary
- Current Price
- As of today, AGMB price is $13.62, down -4.15% on
- Current Price All-Time High
- AGMB price is currently -21.95% below its historical high of $17.45 set on
- Market Cap
- AGMB current market cap is $664M, with unknown 1-year change
- PE Ratio
- AGMB PE ratio is unknown
- Revenue
- AGMB current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for AGMB has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | AgomAb Therapeutics NV American Depositary Shares |
| Ticker | NASDAQ: AGMB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Belgium |
| IPO | |
| Indexes | Not included |
| Website | agomab.com |
| Employees | 57 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $13.62 | ||
| Price, 1D Change | -4.15% | |
| $664M | ||
| - | ||
| - | ||
| 1.03 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.03 | ||
| EPS, 1Y Change | -306.37% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.03 | ||
| EPS Estimate | N/A | -$2.64 |
| EPS Est. Change | N/A | -156.79% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $13.62 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.64 | N/A | - | |
| -$1.87 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| 0.00% | ||
| 0.00% | ||
| -306.37% | ||
| -484.79% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $13.62 | ||
| $15.40 | ||
| SMA 200 vs Price | +13.04% | |
| $15.40 | ||
| SMA 50 vs Price | +13.04% | |
| 1.03 | ||
| $1.05 | ||
| 30.91 | ||
| 50.78% | ||
| 54.82% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.03 | ||
| -$336.40K | ||
| - | ||
| -$53.48M | ||
| - | ||
| -$50.05M | ||
| - | ||
| -$53.15M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 19.02 | ||
| 19.02 | ||
| - | ||
| - | ||
| 20.37 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 3.41 | ||
| -37.76 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $194.76M | ||
| $177.55M | ||
| $213.68M | ||
| $179.74M | ||
| $18.93M | ||
| $9.45M | ||
| $1.60M | ||
| $282.70K | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $50.05M | ||
| $53.15M | ||
| $336.40K | ||
| $10.96M | ||
| $336.40K | ||
| $0.00 | ||
| -$426.20K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$50.65M | ||
| -$730.10K | ||
| $104.67M | ||
| $730.10K | ||
| -$51.38M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Morgan Stanley | ||
| Leerink Partners | ||
| JP Morgan |
Analyst sentiment
Institutional ownership
Screeners with AGMB
FAQ
What is the ticker symbol for AgomAb Therapeutics NV American Depositary Shares?
The ticker symbol for AgomAb Therapeutics NV American Depositary Shares is NASDAQ:AGMB
Does AgomAb Therapeutics NV American Depositary Shares pay dividends?
No, AgomAb Therapeutics NV American Depositary Shares does not pay dividends
What sector is AgomAb Therapeutics NV American Depositary Shares in?
AgomAb Therapeutics NV American Depositary Shares is in the Healthcare sector
What industry is AgomAb Therapeutics NV American Depositary Shares in?
AgomAb Therapeutics NV American Depositary Shares is in the Biotechnology industry
What country is AgomAb Therapeutics NV American Depositary Shares based in?
AgomAb Therapeutics NV American Depositary Shares is headquartered in Belgium
When did AgomAb Therapeutics NV American Depositary Shares go public?
AgomAb Therapeutics NV American Depositary Shares initial public offering (IPO) was on May 29, 2024
Is AgomAb Therapeutics NV American Depositary Shares in the S&P 500?
No, AgomAb Therapeutics NV American Depositary Shares is not included in the S&P 500 index
Is AgomAb Therapeutics NV American Depositary Shares in the NASDAQ 100?
No, AgomAb Therapeutics NV American Depositary Shares is not included in the NASDAQ 100 index
Is AgomAb Therapeutics NV American Depositary Shares in the Dow Jones?
No, AgomAb Therapeutics NV American Depositary Shares is not included in the Dow Jones index
When does AgomAb Therapeutics NV American Depositary Shares report earnings?
The date for AgomAb Therapeutics NV American Depositary Shares's next earnings report has not been announced yet
Data Sources & References
- AGMB Official Website agomab.com
- AGMB Profile on Yahoo Finance finance.yahoo.com/quote/AGMB
- AGMB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/agmb